M Segura Bedmar

ORCID: 0000-0002-1957-3816
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmacovigilance and Adverse Drug Reactions
  • Antibiotic Use and Resistance
  • Pharmaceutical Economics and Policy
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pharmaceutical studies and practices
  • Medication Adherence and Compliance
  • Systemic Lupus Erythematosus Research
  • Acute Lymphoblastic Leukemia research
  • Systemic Sclerosis and Related Diseases
  • Ocular Oncology and Treatments
  • Lipoproteins and Cardiovascular Health
  • Safe Handling of Antineoplastic Drugs
  • Cancer Immunotherapy and Biomarkers
  • Retinal and Optic Conditions
  • Diphtheria, Corynebacterium, and Tetanus
  • Atherosclerosis and Cardiovascular Diseases
  • Toxoplasma gondii Research Studies
  • Advanced Text Analysis Techniques
  • Quality and Safety in Healthcare
  • Artificial Intelligence in Healthcare and Education
  • Bacterial biofilms and quorum sensing
  • Chronic Myeloid Leukemia Treatments
  • Multiple Sclerosis Research Studies
  • Antibiotic Resistance in Bacteria

Hospital Universitario de Móstoles
2003-2024

Madrid Health Service
2019-2020

<h3>Background and Importance</h3> Several studies conclude that correct adherence of patients with multiple sclerosis (MS) is related to higher efficacy lower risk relapses, disease progression, hospitalisations, emergency department visits, ultimately health care costs. Therefore, it a priority detect non-adherence in order optimise therapy. <h3>Aim Objectives</h3> To assess daily oral treatment people MS. perform detailed descriptive analysis non-adherent treatments, identifying reasons,...

10.1136/ejhpharm-2024-eahp.211 article EN Section 4: Clinical pharmacy services 2024-03-01

<h3>Background and Importance</h3> Our country's legislation bans the return of dispensed drugs to Pharmacy Services, potentially leading increased costs for National Health System. <h3>Aim Objectives</h3> To estimate cost pill wastage due dose modifications discontinuation oral anticancer drugs. <h3>Material Methods</h3> Retrospective economic evaluation carried out in an intermediate complexity hospital. Using electronic medical record, dispensations between July 2022 2023 were identified....

10.1136/ejhpharm-2024-eahp.467 article EN 2024-03-01

<h3>Background and Importance</h3> Multiple myeloma (MM) is an incurable chronic disease, so the quality of life (QoL) patients with MM important criterion to consider. The patient-reported outcomes (PROs) are a fundamental tool know success treatment in clinical practice. <h3>Aim Objectives</h3> Assessing QoL as PROs adult treated daratumumab. <h3>Material Methods</h3> Retrospective observational study which included daratumumab between 01/2019 04/2023 second-level Hospital. electronic...

10.1136/ejhpharm-2024-eahp.182 article EN Section 4: Clinical pharmacy services 2024-03-01

<h3>Background and Importance</h3> The life expectancy of people living with HIV (PLHIV) has risen. However, PLHIV present chronic systemic inflammation, which results in premature ageing an increased risk age-associated comorbidities compared to the general population. <h3>Aim Objectives</h3> To determine prevalence among who are 65 years old or above, categorise their distribution multimorbidity patterns according study by Prado Torres et al: cardio-metabolic, depressive-geriatric...

10.1136/ejhpharm-2024-eahp.208 article EN Section 4: Clinical pharmacy services 2024-03-01

espanolObjetivo: Objetivo: Mostrar la eficacia del interferon alfa- 2b topico (IFN 2b) y subconjuntival para el tratamiento de carcinomas conjuntivales intraepiteliales (CIN) en pacientes los cuales existe resistencia, intolerancia o contraindicacion con Mitomicina C ( MMC) topica. Metodo: Se trataron 4 ojos edades comprendidas entre 52 70 anos, diagnostico histopatologico CIN recidivante. En dos se desarrollo una resistencia a MMC topica, otro paciente hubo al ultimo existia empleo debido...

10.4321/s0365-66912003000500006 article ES cc-by-nc Archivos de la Sociedad Española de Oftalmología 2003-05-01

On the 20th of March 2020, triggered by public health emergency declared,  Health Authorities in Madrid reported a legal instruction (Orden 371/2020)  indicating organization provisional hospital to admit patients with  COVID-19 at Trade Fair Institution (IFEMA). Several pharmacists working in  Pharmacy and Medical Devices Department of Regional Health  Service were called manage the Pharmacy Department the  abovementioned hospital. Required permissions to set up PD here  authorized...

10.7399/fh.11491 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2020-06-01

<h3>Background</h3> The treatment of rare autoimmune diseases presents for patients the additional problem limited therapeutic options, which are usually reduced to corticosteroids and immunosuppressants. use rituximab could be an effective alternative. <h3>Purpose</h3> To determine efficacy with in diseases. <h3>Material methods</h3> Retrospective observational study who were treated between January 2008–March 2014. Data was collected from electronic prescription records. Diagnosis, reason...

10.1136/ejhpharm-2015-000639.190 article EN 2015-03-01

<h3>Background</h3> Biological drugs (BD) for autoimmune inflammatory disease (AID) treatment are associated with increased lipids in many studies. Patients AID have an cardiovascular risk comparable that of diabetes mellitus patients, and need tight control. <h3>Purpose</h3> To determine the prevalence hypercholesterolaemia (HP) patients treated BD compared general population. study whether there differences between diseases or BD. assess if hypercholesterolaemic properly treated....

10.1136/ejhpharm-2016-000875.563 article EN 2016-02-14

<h3>Background</h3> Drug shortages are caused by many factors, therefore medicines errors reported. It is necessary to know how much health quality a concern of clinical practice and patient safety involved. <h3>Purpose</h3> To check out the drug supply problems; analyse characteristics assess their impact on medium-sized hospital. <h3>Material methods</h3> A retrospective study issues was conducted from September 2012 2014. Variables analysed: type drug, expected duration shortage...

10.1136/ejhpharm-2015-000639.365 article EN 2015-03-01

<h3>Background</h3> Medication errors, specifically the lack of continuity patient’s usual treatment, are a major cause adverse effects in hospitalised patients, most them preventable. Medicines reconciliation is process comparing prescriptions for medicines to all patient has been taking. <h3>Purpose</h3> To analyse impact different clinical services depending on discrepancies identified and severity errors (MEs). <h3>Materials Methods</h3> Retrospective, descriptive study conducted at...

10.1136/ejhpharm-2013-000276.022 article EN European Journal of Hospital Pharmacy 2013-03-01
Coming Soon ...